Kwaliteitsbewaking Klinische Geneesmiddelanalyse en Toxicologie

Concentration tests and controls.

Content here.
Content here.
Content here.
Content here.

Concentration tests 2020

Components Unit Round 2020.1 Round 2020.2 Round 2020.3 Round 2020.4
Antiretrovirals I
Atazanavir mg/l 3,73 1,87  0,978
Darunavir mg/l  1,44 2,88 4,795
Dolutegravir mg/l  0,943 0,472  3,37
Elvitegravir mg/l  0,469  1,88  2,34
Lopinavir mg/l 0,934 3,9 5,83
Rilpivirine mg/l  0,101 0,152 0,304
Ritonavir mg/l  2,38 1,91 0,499
Saquinavir mg/l  0,483 0,966 2,89
Antiretrovirals II
Amprenavir mg/l 0,481 5,04  0,971
Efavirenz mg/l  2,84  5,96  1,912
Etravirine mg/l 0,407 0,205 0,137
Nevirapine mg/l 6,29  2,84  1,902
Raltegravir mg/l  7,78  3,91  0,981
Tipranavir mg/l  28,17  56,63  18,94

 

Concentration tests 2019

Components Unit Round 2019.1 Round 2019.2 Round 2019.3 Round 2019.4
Antiretrovirals I
Atazanavir mg/l 2,07 0,149 5,15 0,933
Darunavir mg/l 0,965  5,78  2,88 4,83
Dolutegravir mg/l 5,52 2,21  0,878  0,442
Elvitegravir mg/l 0,927  0,463  2,30 1,85
Lopinavir mg/l  0,895  1,79  3,71 7,46
Rilpivirine mg/l 0,201 0,401  0,299  0,100
Ritonavir mg/l  0,973  2,43  1,81  0,486
Saquinavir mg/l  4,18 2,09  0,498  3,13
Antiretrovirals II
Amprenavir mg/l 0,927 4,97 2,50 0,464
Efavirenz mg/l  6,07  2,02  4,07  1,01
Etravirine mg/l 0,511  0,256  0,154  0,205
Nevirapine mg/l  2,85  5,71  8,51  1,90
Raltegravir mg/l  4,05  0,486  0,979  5,07
Tipranavir mg/l  42,78 21,40  16,16  32,13

 

Concentration tests 2018

Components Unit Round 2018.1 Round 2018.2 Round 2018.3 Round 2018.4
Antiretrovirals I
Atazanavir mg/l  0,505  1,02  0,242 0,760
Darunavir mg/l  0,986  4,95  2,95  1,98
Dolutegravir mg/l  2,83  0,142  0,424  1,07
Elvitegrar mg/l  0,117  2,45  0,972  0,489
Lopinavir mg/l  8,22  2,06  0,738  3,09
Rilpivirine mg/l  0,156  0,440  0,097  0,039
Ritonavir mg/l  1,82  0,972  1,45  2,43
Saquinavir mg/l  1,46  2,94  0,730  0,147
Antiretrovirals II
Amprenavir mg/l  0,456 4,03 1,01 2,52
Efavirenz mg/l  0,982  6,96 4,18  0,780
Etravirine mg/l  0,123  0,183  0,367  0,244
Nevirapine mg/l  2,92  4,83  1,93  5,80
Raltegravir mg/l  0,0259  3,43  2,14  0,857
Tipranavir mg/l  110,1  72,82  36,42  45,51

 

Concentration tests 2017

Components Unit Round 2017.1 Round 2017.2 Round 2017.3 Round 2017.4
Antiretrovirals I
Atazanavir mg/l 1,91  0,459 4,77 0,306
Darunavir mg/l 3,00  2,11  2,40  0,843
Dolutegravir mg/l 0,0984  0,988  2,95 1,48
Elvitegrar mg/l 0,121 1,51  0,754 1,01
Lopinavir mg/l 1,05  7,56  2,64 3,78
Rilpivirine mg/l  —  0,156  0,0313
Ritonavir mg/l 0,388  0,975  1,94 2,44
Saquinavir mg/l 2,91  0,0935  0,466  1,17
Antiretrovirals II
Amprenavir mg/l 0,398 3,92  0,998 3,00
Efavirenz mg/l 0,787  4,65  1,18 3,95
Etravirine mg/l 0,783  0,385  0,147  0,246
Nevirapine mg/l 7,46  2,20  1,87  5,62
Raltegravir mg/l 1,98  0,623  1,19  0,0596
Tipranavir mg/l 19,50  19,18  14,65  39,17

Concentration tests 2016

Components Unit Round 2016.1 Round 2016.2 Round 2016.3 Round 2016.4
Antiretrovirals I
Atazanavir mg/l  0,218  1,51 0,903 3,01
Darunavir mg/l 0,352 6,58 0  3,28
Lopinavir mg/l 10,11 0,968 2,41  0,482
Rilpivirine mg/l  0,0584 0,182 0,363  0,0348
Ritonavir mg/l 0,427 2,67 6,64  0,848
Saquinavir mg/l 0,0964 2,40 0,240  7,17
Antiretrovirals II
Amprenavir mg/l 0,241 0,239 0,400 4,82
Efavirenz mg/l 0,867 5,37 6,47  0,433
Etravirine mg/l  0,165 0,082 0,247  0,826
Nevirapine mg/l  7,06  1,64 4,69  0,494
Raltegravir mg/l 0  0,895 0  1,50
Tipranavir mg/l  16,03  54,91 27,92  10,01

Concentration tests 2015

Components Unit Round 2015.1 Round 2015.2 Round 2015.3 Round 2015.4
Antiretrovirals I
Atazanavir mg/l  1,75  0,215  0,426  0,430
Darunavir mg/l  4,47  0,858  0,530  1,07
Lopinavir mg/l  0,529  12,09  7,96  1,09
Rilpivirine mg/l  0,441  0,0408  1,05  0,109
Ritonavir mg/l  0,977  5,02  1,98  0,752
Saquinavir mg/l  0,0932  2,40  4,73  0,191
Antiretrovirals II
Amprenavir mg/l  5,65  0,793  0,221  2,83
Efavirenz mg/l  4,58  0,661  1,32  1,32
Etravirine mg/l  0,127  0,910  0,338  0,0848
Nevirapine mg/l  15,72  1,70  3,14  1,13
Raltegravir mg/l  0,0144  7,53  0,480  4,52
Tipranavir mg/l  27,66  13,87  58,77  69

Concentration control (matrix: liquid human serum)

Components Weighed-in value
Unit 2020 2019 2018 2017 2016 2015 2014
Antiretrovirals I
Atazanavir mg/l 1,04 0,917 1,05 0,985 0,994 0,982 0,953
Darunavir mg/l  4,84 5,13 4,92 4,96 4,51 5,03 4,81
Dolutegravir mg/l  1,41 1,47 1,47 1,53
Elvitegravir mg/l  1,05 1,03 1,02 1,04
Lopinavir mg/l  6,54 6,61 6,84 7,01  6,91 6,62 7,09
Nelfinavir mg/l 2,04
Rilpivirine mg/l  0,284 0,311 0,292 0,302  0,299 0,298
Ritonavir mg/l  5,00 4,84 5,04 5,02  4,93 4,95 5,05
Saquinavir mg/l  1,35 1,39 1,52 1,50 1,48 1,57 1,48
Antiretrovirals II
Amprenavir mg/l 1,95 1,90 2,08 2,06 1,97 1,93 2,01
Efavirenz mg/l  2,46 2,32 2,30 2,55  2,66 2,50 2,53
Etravirine mg/l  0,980 1,06 1,01 1,02 1,02 1,03 0,977
Nevirapine mg/l  4,09 3,88 3,99 3,87 3,85 4,02 4,00
Raltegravir mg/l  1,90 1,86 2,12 2,05 1,97 2,05 1,94
Tipranavir mg/l  15,26 14,73 15,03 15,16  14,76 15,72 14,81
Back to Top